  |
Lægemiddelstofklassifikation ATC |
M | ||
  |
Antineoplastiske og immunomodulerende midler |
ML | ||
  |
immunstimulerende midler |
ML03 | ||
  |
immunstimulanter |
ML03A | ||
|
interferoner |
ML03AB | ||
 |
interferon alfa naturligt |
ML03AB01 | ||
 |
interferon beta naturligt |
ML03AB02 | ||
 |
interferon gamma |
ML03AB03 | ||
 |
interferon alfa-2A |
ML03AB04 | ||
 |
interferon alfa-2B |
ML03AB05 | ||
 |
interferon alfa-N1 |
ML03AB06 | ||
 |
interferon beta-1A |
ML03AB07 | ||
 |
interferon beta-1B |
ML03AB08 | ||
 |
interferon alfacon-1 |
ML03AB09 | ||
 |
Peginterferon alfa-2B |
ML03AB10 | ||
 |
peginterferon alfa-2A |
ML03AB11 | ||
 |
albinterferon alfa-2B |
ML03AB12 | ||
 |
peginterferon beta-1A |
ML03AB13 | ||
 |
cepeginterferon alfa-2B |
ML03AB14 | ||
 |
ropeginterferon alfa-2b |
ML03AB15 | ||
 |
peginterferon alfacon-2 |
ML03AB16 | ||
 |
sampeginterferon beta-1a |
ML03AB17 | ||
 |
peginterferon-alfa-2B, komb. |
ML03AB60 | ||
 |
peginterferon alfa-2A, kombinationer |
ML03AB61 |
TEXT